BBSC - ETF AI Analysis
Top Page
JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC)
Rating:62Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown strong gains so far this year and over the last few months, indicating solid recent momentum.
Low Expense Ratio
The fund charges a relatively low fee, which helps investors keep more of the returns generated by the portfolio.
Broad Sector Diversification
Holdings are spread across many sectors, including technology, health care, financials, and industrials, which helps reduce the impact of weakness in any single industry.
Negative Factors
Heavy U.S. Focus
Almost all of the ETF’s assets are invested in U.S. companies, offering very limited international diversification.
Small-Cap Volatility Risk
Because the fund targets smaller companies, its share price can be more sensitive to market swings and economic downturns.
Concentration in Top Sectors
A large portion of the portfolio is concentrated in technology, health care, and financials, which could hurt performance if these areas weaken.
BBSC vs. SPDR S&P 500 ETF (SPY)
AUM726.58M
RegionNorth America
Expense Ratio0.09%
Beta1.09
IssuerJPMorgan
Inception DateNov 16, 2020
Dividend Yield1.03%
Asset ClassEquity
Index TrackedMorningstar US Small Cap Target Market Exposure Extended Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume10,765
30 Day Avg. Volume9,878
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
111.52Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering845
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BBSC Summary
JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) is an ETF that follows the Morningstar US Small Cap Target Market Exposure Extended Index, focusing on smaller U.S. companies with room to grow. It holds hundreds of stocks across many sectors, including technology, health care, and financials. Some recognizable names in the fund are Semtech and DigitalOcean Holdings. Investors might consider BBSC to add diversification and long-term growth potential from smaller, more innovative businesses. A key risk is that small-cap stocks can be more volatile than larger companies, so the value of this ETF can go up and down sharply with the market.
How much will it cost me?The JPMorgan BetaBuilders U.S. Small Cap Equity ETF (BBSC) has an expense ratio of 0.09%, meaning you’ll pay $0.90 per year for every $1,000 invested. This is lower than average because it’s passively managed, aiming to track an index rather than actively selecting stocks.
What would affect this ETF?The BBSC ETF, focused on U.S. small-cap stocks, could benefit from economic growth and innovation within sectors like technology, health care, and industrials, as smaller companies often thrive during periods of expansion. However, it may face challenges from rising interest rates, which can increase borrowing costs for small-cap firms, and economic slowdowns that disproportionately impact smaller businesses. Additionally, sector-specific risks, such as regulatory changes in health care or energy, could influence performance.
BBSC Top 10 Holdings
BBSC is a pure U.S. small-cap play, and its story right now is being written mostly by health care and tech names. Corcept Therapeutics and Krystal Biotech are helping pull the fund higher with rising momentum, while Arrowhead Pharmaceuticals is steady but still wrestling with financial growing pains. On the tech side, Semtech and JFrog are climbing, though their rich valuations and lack of consistent profits add some wobble to the ride. Overall, performance is driven by a broad mix of smaller innovators rather than a few dominant giants.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 1.85% | $13.36M | ― | ― | ― | |
| Semtech | 0.59% | $4.24M | $15.61B | 177.35% | 69 Neutral | |
| Corcept Therapeutics | 0.45% | $3.24M | $12.19B | 54.78% | 76 Outperform | |
| Moog | 0.41% | $2.98M | $11.62B | 85.32% | 73 Outperform | |
| American Healthcare REIT, Inc. | 0.41% | $2.97M | $11.76B | 25.57% | 64 Neutral | |
| Arrowhead Pharmaceuticals | 0.40% | $2.92M | $11.70B | 178.77% | 57 Neutral | |
| DigitalOcean Holdings | 0.39% | $2.83M | $14.46B | 244.49% | 73 Outperform | |
| Brinker International | 0.37% | $2.64M | $8.87B | 38.28% | 70 Neutral | |
| SM Energy | 0.36% | $2.62M | $9.06B | 42.48% | 72 Outperform | |
| JFrog | 0.36% | $2.61M | $10.75B | 74.57% | 73 Outperform |
BBSC Technical Analysis
Negative
―
Price Trends
90.53
Negative
88.18
Negative
82.55
Positive
Market Momentum
-0.67
Positive
38.73
Neutral
6.64
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BBSC, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 90.51, equal to the 50-day MA of 90.53, and equal to the 200-day MA of 82.55, indicating a neutral trend. The MACD of -0.67 indicates Positive momentum. The RSI at 38.73 is Neutral, neither overbought nor oversold. The STOCH value of 6.64 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BBSC.
BBSC Peer Comparison
Comparison Results
Performance Comparison
BBSC
JPMorgan BetaBuilders U.S. Small Cap Equity ETF
88.10
15.50
21.35%
SFLO
VictoryShares Small Cap Free Cash Flow ETF
―
―
―
OUSM
OShares U.S. Small-Cap Quality Dividend ETF
―
―
―
JHSC
John Hancock Multifactor Small Cap ETF
―
―
―
EES
WisdomTree U.S. SmallCap Fund
―
―
―
SMDV
ProShares Russell 2000 Dividend Growers ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents